Attention:

Certain features of Sigma-Aldrich.com will be down for maintenance the evening of Friday August 18th starting at 8:00 pm CDT until Saturday August 19th at 12:01 pm CDT.   Please note that you still have telephone and email access to our local offices. We apologize for any inconvenience.

Neuropeptide Y and Peptide YY

Product #

Description

Biochem/physiol Actions

Add to Cart

B174 BIBP 3226 Selective non-peptide neuropeptide Y1 (NPY1) receptor antagonist.
N9398 N-Acetyl-[Leu28, Leu31]-Neuropeptide Y Fragment 24-36 ≥98% (HPLC), powder N-Acetyl-[Leu28, Leu31]-Neuropeptide Y Fragment 24-36 is a neuropeptide Y-Y2 receptor agonist.
Selective neuropeptide Y-Y2 receptor agonist.
P4488 Pancreatic Polypeptide Fragment 1-17–[Ala31, α-Aminoisobutyryl32]-Neuropeptide Y Fragment 18-36 ≥95% (HPLC), solid Selective agonist of the neuropeptide Y receptor.
N5017 Neuropeptide Y human ≥95% (HPLC), powder, synthetic Neuropeptide Y (NPY) plays a vital role in various processes including feeding behaviour, anxiety, epilepsy, circadian, as well as rhythm memory processing, sleep, pain and drug addiction. In addition, it is also implicated in regulation of appetite, body weight and obesity. It controls central endocrine secretion and has potent vasoactive effects on the cardiovascular system. NPY is involved in the pathogenesis of atherosclerosis and coronary artery disease. NPY exhibits antimicrobial activity against Cryptococcus neoformans, Candida albicans and Arthroderma simii.
Vasoconstrictor; brain peptide that inhibits Ca2+-activated K+ channels in vascular smooth muscle. Implicated in the control of blood pressure, sexual behavior and food intake. Inhibits cholecystokinin- and secretin-stimulated pancreatic secretion.
N9528 Anti-Neuropeptide Y (NPY) antibody produced in rabbit whole antiserum  
N3266 Neuropeptide Y porcine ≥97% (HPLC), synthetic Vasoconstrictor; brain peptide that inhibits Ca2+-activated K+ channels in vascular smooth muscle. Implicated in the control of blood pressure, sexual behavior and food intake. Inhibits cholecystokinin- and secretin-stimulated pancreatic secretion.
N9407 Neuropeptide Y Fragment 3-36 human, rat ≥95% (HPLC) Endogenous neuropeptide that selectively binds to Y2 and Y5 receptors.
N6521 Neuropeptide Y Fragment 13-36 porcine ≥97% (HPLC) Selective neuropeptide Y2 receptor agonist.
P4107 [Leu31, Pro34]-Peptide YY ≥95% Agonist at Y1, Y4, and Y5 NPY receptors.
P3982 [Pro34]-Peptide YY ≥95% NPY agonist with a preference for the Y1 and Y5 subtypes.
P220 Peptide YY Fragment 3-36 human ≥95% (HPLC), lyophilized powder Y2/Y5 Neuropeptide Y receptor agonist.
P1306 Peptide YY human ≥97% (HPLC), synthetic Gut hormone that inhibits both secretin and cholecystokinin-stimulated pancreatic secretion. Endogenous nonselective agonist at NPY receptors.
P5801 Peptide YY porcine ≥97% (HPLC), synthetic Gut hormone that inhibits both secretin and cholecystokinin-stimulated pancreatic secretion. Endogenous nonselective agonist at NPY receptors.